Interferons are signaling proteins your body releases when it detects a threat, most commonly a virus. They act as an early alarm system: an infected cell produces interferons to warn neighboring cells, triggering a cascade of protective responses that slow viral spread, activate immune cells, and even help fight cancer. There are three main types, each with distinct roles in keeping you healthy.
Three Types With Different Jobs
Your body produces three families of interferons, classified as Type I, Type II, and Type III. Type I interferons (including interferon-alpha and interferon-beta) are the broadest in scope. Nearly every cell in your body can produce them, though a specialized immune cell called the plasmacytoid dendritic cell is the primary source. These interferons bind to a shared receptor found on virtually all cell types, which is why their effects are so widespread.
Type II interferon has only one member: interferon-gamma. Rather than being a general alarm signal, interferon-gamma is produced mainly by specific immune cells (T cells and natural killer cells) and focuses on coordinating the immune response against bacteria, parasites, and tumor cells. It’s particularly important for activating the cells that engulf and destroy pathogens.
Type III interferons (the interferon-lambda family) work through a different receptor that’s concentrated on cells lining your respiratory tract, gut, and other mucosal surfaces. Intestinal lining cells preferentially produce this type, making it especially important as a first line of defense at the body surfaces where infections often begin.
How Interferons Block Viruses
The most well-known role of interferons is antiviral defense, and the mechanism is remarkably thorough. When a cell detects viral material inside itself, it releases Type I interferons. These molecules travel to neighboring cells, dock on their surface receptors, and switch on a signaling chain inside the cell. This chain, called the JAK-STAT pathway, ultimately activates hundreds of genes known as interferon-stimulated genes, or ISGs. The proteins these genes produce form a multi-layered barrier against viral infection.
Some of these proteins block viruses from even entering a cell. A family of proteins called IFITMs appears to disrupt the process viruses use to slip through cell membranes, and they’ve been shown to work against influenza, dengue, Ebola, SARS-CoV, and HIV. Other proteins attack the virus at later stages. One protein, called MxA, interferes with how viruses like influenza copy their genetic material once inside a cell. Another group, the OAS proteins, activates an enzyme that chews up viral genetic material directly.
Still other defenses target the final stages of a virus’s life cycle. A protein called tetherin physically prevents newly made viral particles from detaching and spreading to other cells, a mechanism that’s particularly relevant in HIV infection. Viperin disrupts the fatty structures on the cell surface that influenza uses as a launchpad. And a protein called PKR shuts down the cell’s protein-making machinery, which starves viruses of the equipment they need to reproduce. The trade-off is that the cell’s own protein production suffers too, but it’s a sacrifice that limits the infection.
This layered approach means interferons don’t rely on any single mechanism. A virus that evolves to dodge one defense still faces several others.
Fighting Bacteria and Other Pathogens
While Type I interferons get the most attention for antiviral defense, interferon-gamma (Type II) plays a central role in fighting bacterial infections. Its primary job is supercharging immune cells that physically engulf and destroy bacteria. When interferon-gamma reaches these cells, it ramps up their ability to produce reactive oxygen species, which are toxic molecules that kill bacteria trapped inside the cell. Research on Staphylococcus aureus infections has shown that interferon-gamma enhances both the production of these toxic molecules and the actual killing of bacteria by immune cells.
Interferon-gamma also triggers immune cells to release chemical signals that recruit more defenders to the site of infection, amplifying the inflammatory response. This is why interferon-gamma is considered essential for controlling infections caused by bacteria that hide inside your cells, such as the bacterium that causes tuberculosis.
The Role in Cancer Defense
Interferons contribute to cancer defense through both direct and indirect mechanisms. Interferon-alpha can slow tumor growth by triggering programmed cell death (apoptosis) in cancer cells. It does this by activating genes that produce death-signaling molecules on the cell surface. These molecules activate a chain of enzymes inside the cancer cell that systematically dismantle it from within.
The indirect effects are equally important. Interferon-alpha boosts the cancer-killing activity of both T cells and natural killer cells, two immune cell types that patrol for abnormal cells. It also increases the visibility of cancer cells to the immune system by forcing them to display more identification markers on their surface, making it harder for tumors to hide. Additionally, interferons can inhibit the growth of new blood vessels that tumors need to feed themselves, cutting off their supply lines.
Interferon-Based Treatments
Because interferons are so effective at modulating immune responses, synthetic versions have become important medications. Pegylated interferon-alpha remains one of the two main treatment approaches for chronic hepatitis B. Administered as a weekly injection over 48 weeks, it achieves a sustained loss of viral activity markers in about 30% of patients. Its advantage over the alternative (daily antiviral pills) is that treatment has a defined endpoint rather than requiring indefinite use.
In multiple sclerosis, interferon-beta has been a standard treatment for over two decades. Clinical trials showed it reduces the annual relapse rate by 27 to 33% compared to placebo, depending on the dose. The treatment works by dampening the overactive immune response that damages the protective coating around nerve fibers.
Interferon therapy does come with significant side effects, precisely because it activates such broad immune and inflammatory pathways. Fatigue, fever, and muscle aches are common, essentially mimicking the feeling of having the flu. The immune system and nervous system are deeply interconnected, and interferon treatment can trigger psychiatric symptoms including depression, anxiety, irritability, insomnia, and difficulty concentrating. These effects are driven by the same inflammatory signaling that makes interferons effective, which means they’re difficult to separate from the therapeutic benefit.
Interferons as a Diagnostic Tool
Interferon-gamma also has a practical role in diagnosing disease. The QuantiFERON-TB Gold test, used to screen for latent tuberculosis, works by measuring how much interferon-gamma your immune cells produce when exposed to tuberculosis-specific proteins. A blood sample is mixed with these proteins and incubated for 24 hours. If your T cells have previously encountered tuberculosis bacteria, they’ll recognize the proteins and release interferon-gamma, producing a positive result. This test has largely replaced the traditional skin test in many settings because it requires only a single blood draw and doesn’t require a follow-up visit to read results.
When Interferons Fail: Lessons From COVID-19
The COVID-19 pandemic revealed just how critical interferons are to surviving severe infections. A striking finding published in The Lancet Rheumatology showed that roughly 14% of patients with life-threatening COVID-19 pneumonia carried pre-existing autoantibodies, immune proteins that mistakenly attack and neutralize the body’s own Type I interferons. These patients essentially had a hidden gap in their immune armor that went unnoticed until they faced a serious viral challenge. Without functional interferons to mount an early defense, the virus replicated unchecked in the critical early days of infection, leading to the severe inflammation and organ damage that characterized the worst COVID-19 outcomes.
This discovery underscored a broader principle: interferons are most valuable in the first hours and days of an infection, when they buy time for the rest of the immune system to mobilize. When that early window is lost, whether because of genetic defects, autoantibodies, or viral evasion strategies, the consequences can be severe.